The potentials of proton beam radiation therapy in malignant lymphoma, thymoma and sarcoma.

• A group of Swedish oncologists and hospital physicists have estimated the number of patients in Sweden suitable for proton beam therapy. The estimations have been based on current statistics of tumour incidence, number of patients potentially eligible for radiation treatment, scientific support from clinical trials and model dose planning studies and knowledge of the dose-response relations of different tumours and normal tissues. Besides sarcomas of the base of skull, which are classical sites for proton beam therapy, it is estimated that about 40 patients yearly in Sweden with sarcomas at other sites are candidates for proton beam therapy. About 20 patients each with malignant lymphomas, chiefly in the mediastinum, and thymomas are also candidates to decrease doses to surrounding heart and lungs.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Nyckelord

Humans

Lymphoma

radiotherapy

Models

Biological

Protons

therapeutic use

Radiotherapy Dosage

Radiotherapy Planning

Computer-Assisted

methods

Sarcoma

radiotherapy

Sweden

Thymoma

radiotherapy

Oncology

Publikations- och innehållstyp

ref (ämneskategori)

art (ämneskategori)